Cowen Starts Liquidia Technologies (LQDA) at Outperform
Tweet
Share
E-mailGet Alerts LQDA Hot Sheet
Price: $36.03 +4.37%
Rating Summary:
11 Buy, 0 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
11 Buy, 0 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Cowen analyst Ken Cacciatore initiates coverage on Liquidia Technologies (NASDAQ: LQDA) with a Outperform rating and a price target of $40.00.
The analyst comments "The lead asset is LIQ861 for PAH, an inhaled reformulation of a known active molecule, treprostinil, that is more optimally designed and should rapidly transition, convert and expand a current $400MM target market. We would add."
For an analyst ratings summary and ratings history on Liquidia Technologies click here. For more ratings news on Liquidia Technologies click here.
Shares of Liquidia Technologies closed at $14.90 yesterday.
Create E-mail Alert Related Categories
Analyst Comments, New CoverageRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
